Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

American journal of epidemiology

Volumn 176, Issue 2, 2012, Pages 156-163

  Schenk, Jeannette M ^a   Calip, Gregory S ^b   Tangen, Catherine M ^b   Goodman, Phyllis ^b   Parsons, J Kellogg ^b   Thompson, Ian M ^b   Kristal, Alan R ^b  

^a USA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

AGED; ARTHRITIS; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEADACHE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MUSCULOSKELETAL DISEASE; OBESITY; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING; STATISTICAL MODEL;

ACETAMINOPHEN; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; ASPIRIN; COHORT STUDIES; COMORBIDITY; HEADACHE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, STATISTICAL; MUSCULOSKELETAL DISEASES; OBESITY; OVERWEIGHT; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RISK FACTORS; SMOKING;

EID: 84866245273     PISSN: None     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr524     Document Type: Article

References (0)